Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIG | 39.5 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIG | 66.0 | 80 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIG | 38.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | MIG | 40.0 | 50 | |
N2586 | 3 | MIG | 49.0 | 77 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | MIG | 18.5 | 62 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | MIG | 19.5 | 58 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 16.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 22.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 21.5 | 68 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | MIG | 20.0 | 73 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | MIG | 19.5 | 84 | ||||
N2586 | EGF | 100 | ng/mL | 3 | MIG | 55.5 | 66 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | MIG | 71.5 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 54.0 | 71 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 90.0 | 57 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIG | 41.5 | 72 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | MIG | 39.0 | 65 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | MIG | 30.0 | 55 | ||||
RA2159 | 3 | MIG | 16.0 | 65 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | MIG | 14.5 | 56 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | MIG | 14.5 | 66 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | MIG | 19.0 | 52 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | MIG | 16.0 | 53 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | MIG | 16.0 | 50 |